USP22 expression is associated with lymph node metastasis, distant metastasis, TNM stage and poor OS of GC patients but is not associated with age, gender, depth of invasion, tumor differentiation and tumor size. The gene discussed is USP22; the disease is metastatic malignant neoplasm in the lymph nodes.